Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic) (DeathPercep)

Real or Concieved Death Number Perception in Depression, Anxiety and in Schizotypal Personality Disorder Following Covid-19 Pandemic Lockdown

France has been put on a lockdown for 8 weeks to prevent the spread of the COVID-19 virus between 17/03/2020 and 11/05/2020. During this lockdown, which is likely to have psychopathological repercussions on the population, the public authorities and the media informed the population about the number of deaths occurring each day. While the functioning of autobiographical memory following traumatic events remains a debate in the literature, the impact of the daily announcement of mass deaths on the memory system in the general population and the relationship between long-term memory and delusional thinking in certain psychopathologies have yet to be explored in the literature.

The investigators wish to demonstrate that self-reported recall of recorded deaths may represent this distortion of perception, symptomatic of these pathologies by an on-line questionnaire.

Study Overview

• Status: Completed
• Conditions: Mental Disorder; General Population

Detailed Description

Indeed, it has been reported that under continued stress, delusions and psychotic experiences can occur in the general population. This phenomenon is found in individuals suffering from depression and anxiety and schizotypal personality disorder.

The investigators wish to demonstrate that self-reported recall of recorded deaths may represent this distortion of perception, symptomatic of these pathologies.

Thus, using an online longitudinal questionnaire, the investigators wish to explore :

• how the memory system is impacted by mass deaths over several trimesters in the general population.
• whether the long-term memory of people suffering from depression and anxiety disorders and people suffering from schizotypal personality disorder contains recollection of a distorted pattern in relation to the actual number of deaths.

Primary goals of this project are:

Determine, in the context of mass deaths, the level and proportion of real or conceived recall of the number of deaths in the general population based on cognitive and affective empathy profiles over four trimesters.

Also the investigators want to determine

• the proportion of real or conceived recall numbers of deaths by COVID-19 among people suffering from depression and anxiety in a context of mass death.
• the proportion of real or conceived recall number of deaths by COVID-19 among people with schizotypal personality disorder.
• the dynamics of this real or conceived recall for four trimester following the end of lockdown.

Methodology:

The entire study will be conducted online. Participants will provide their informed consent. At these assessment, they will provide a set of self report measures associated to COVID-19 related psychological aspects especially for depression, anxiety and schizotypal personality.

Subjects can only participate once.

Sample size:

There is no minimum/maximum sample size for this study. The study will remain open for 1 year. The sample size should reach 1000 participants at least.

List of self-report measures:

• Brief Trauma Questionnaire (BTQ)
• COVID-Related Thoughts and Behavioral Symptoms (COV-TaBS)
• Beck Depression Inventory (BDI)
• State and Trait Anxiety Inventory (STAI)
• The Hospital Anxiety and Depression Scale (HAPS)
• Questionnaire of Cognitive and Affective Empathy (QCAE)
• Raine Schizotypal Personality Questionnaire, (SPQ)
• Paranoia Scale

• Study Type: Observational
• Enrollment (Actual): 1000

Contacts and Locations

Study Locations

• France
  • Montpellier, France, 34295
    • UH Montpellier

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

General population with self reported depression, anxiety and schizotypal personnality and without mental health conditions

Description

Inclusion criteria:

• Individuals from the general population
• French native speacker
• Majority 18 years and more

Exclusion criteria:

• Patient refusing to participate in research

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
number of perception distortions	number of perception distortions	1 day

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Recall number of deaths	Recall number of deaths	1 day

Collaborators and Investigators

• Sponsor: University Hospital, Montpellier
• Collaborators: University of Montpellier 3 (Pr. Stéphane Raffard, PhD); University of Reims Champagne-Ardenne (Ali Oker PhD)

Study record dates

Study Major Dates

• Study Start (Actual): May 29, 2020
• Primary Completion (Actual): May 30, 2021
• Study Completion (Actual): June 1, 2021

Study Registration Dates

• First Submitted: May 5, 2020
• First Submitted That Met QC Criteria: May 10, 2020
• First Posted (Actual): May 12, 2020

Study Record Updates

• Last Update Posted (Actual): January 11, 2022
• Last Update Submitted That Met QC Criteria: January 10, 2022
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19; Mental Disorders
• Other Study ID Numbers: RECHMPL20_0276

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: NC

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No